Literature DB >> 17110658

2006: a stroke odyssey.

Thomas A Tomsick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17110658      PMCID： PMC7977232     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  14 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Combined IV and intra-arterial thrombolysis for acute ischemic stroke.

Authors:  M L Flaherty; D Woo; B Kissela; E Jauch; A Pancioli; J Carrozzella; J Spilker; P Sekar; J Broderick; T Tomsick
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

3.  Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial.

Authors:  Wade S Smith; Gene Sung; Sidney Starkman; Jeffrey L Saver; Chelsea S Kidwell; Y Pierre Gobin; Helmi L Lutsep; Gary M Nesbit; Thomas Grobelny; Marilyn M Rymer; Isaac E Silverman; Randall T Higashida; Ronald F Budzik; Michael P Marks
Journal:  Stroke       Date:  2005-06-16       Impact factor: 7.914

4.  Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.

Authors:  T G Brott; E C Haley; D E Levy; W Barsan; J Broderick; G L Sheppard; J Spilker; G L Kongable; S Massey; R Reed
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

5.  Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset.

Authors:  E C Haley; D E Levy; T G Brott; G L Sheppard; M C Wong; G L Kongable; J C Torner; J R Marler
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

6.  Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA).

Authors:  H Zeumer; H J Freitag; F Zanella; A Thie; C Arning
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

7.  Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?

Authors:  C Berger; M Fiorelli; T Steiner; W R Schäbitz; L Bozzao; E Bluhmki; W Hacke; R von Kummer
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  NXY-059 for acute ischemic stroke.

Authors:  Kennedy R Lees; Justin A Zivin; Tim Ashwood; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; James Grotta; Patrick Lyden; Ashfaq Shuaib; Hans-Göran Hårdemark; Warren W Wasiewski
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

10.  North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke.

Authors:  Brian R Mahon; Gary M Nesbit; Stanley L Barnwell; Wayne Clark; Thomas R Marotta; Alain Weill; Phillip A Teal; Adnan I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825
View more
  3 in total

Review 1.  Equipoise among recanalization strategies.

Authors:  T A Tomsick; P Khatri; T Jovin; B Demaerschalk; T Malisch; A Demchuk; M D Hill; E Jauch; J Spilker; J P Broderick
Journal:  Neurology       Date:  2010-03-30       Impact factor: 9.910

2.  Capillary Index Score in the Interventional Management of Stroke trials I and II.

Authors:  Firas Al-Ali; Thomas A Tomsick; John J Connors; James M Gebel; John J Elias; Georges Z Markarian; Zein Al-Ali; Joseph P Broderick
Journal:  Stroke       Date:  2014-05-22       Impact factor: 7.914

3.  Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data.

Authors:  Joseph P Broderick; Olvert A Berkhemer; Yuko Y Palesch; Diederik W J Dippel; Lydia D Foster; Yvo B W E M Roos; Aad van der Lugt; Thomas A Tomsick; Charles B L M Majoie; Wim H van Zwam; Andrew M Demchuk; Robert J van Oostenbrugge; Pooja Khatri; Hester F Lingsma; Michael D Hill; Bob Roozenbeek; Edward C Jauch; Tudor G Jovin; Bernard Yan; Rüdiger von Kummer; Carlos A Molina; Mayank Goyal; Wouter J Schonewille; Mikael Mazighi; Stefan T Engelter; Craig S Anderson; Judith Spilker; Janice Carrozzella; Karla J Ryckborst; L Scott Janis; Kit N Simpson
Journal:  Stroke       Date:  2015-10-20       Impact factor: 7.914
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.